Medicines: Atezolizumab

Real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic UC

Key outcomes of the Phase 1b of atezolizumab and bevacizumab for advanced HCC

Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC

ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC

European Society for Medical Oncology (ESMO)

Atezolizumab’s Role in Treating Nondriver NSCLC

Targeted Oncology

Atezolizumab + Bevacizumab in Treatment-Naïve mRCC

UK's National Health Service to roll out first cancer treatment jab | WION

WION

The FDA Approval of Atezolizumab in Bladder Cancer

Menstrual cycle#medicine#healthtips #healthcare#symptoms #treatment#doctor#menstruation#womenhealth

Atezolizumab and Bevacizumab Studied in Patients With Metastatic RCC

Targeted Oncology

Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC

IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC

Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Title: Atezolizumab (MPDL3280A): Harnessing Immunotherapy's Promise in Cancer Treatment | GlpBio

Adjuvant atezolizumab in NSCLC

Atezolizumab and bevacizumab for upfront unresectable HCC

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

World's First 7-Minute Cancer Treatment Jab To Be Rolled Out In England: How It Works

Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer

Dana-Farber Cancer Institute